We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · August 20, 2020

Clinical Implications of BMI in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy

Journal of the National Cancer Institute

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the National Cancer Institute
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy
J. Natl. Cancer Inst 2020 Aug 04;[EPub Ahead of Print], MA Franzoi, D Eiger, L Ameye, N Ponde, R Caparica, C De Angelis, M Brandão, C Desmedt, S Di Cosimo, N Kotecki, M Lambertini, A Awada, M Piccart, E de Azambuja

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading